MedPath
TGA Approval

ADACEL POLIO pertussis vaccine - acellular diphtheria and tetanus toxoids (adsorbed) combined with inactivated poliovirus 0.5mL injection syringe (106576)

106576

ADACEL POLIO pertussis vaccine - acellular diphtheria and tetanus toxoids (adsorbed) combined with inactivated poliovirus 0.5mL injection syringe

Sanofi-Aventis Australia Pty Ltd

June 6, 2006

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/942527bca93eea3a287d01e73754b5c4.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/98a6e325c7feb887758aaf8520a8f4dd.pdf

Active Ingredients

Diphtheria toxoid

Pertactin

Pertussis toxoid

Tetanus toxoid

Poliovirus

Pertussis filamentous haemagglutinin

Pertussis fimbriae 2 + 3

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ADACEL POLIO pertussis vaccine - acellular diphtheria and tetanus toxoids (adsorbed) combined with inactivated poliovirus 0.5mL injection syringe (106576) - TGA 批准文号 | MedPath